Literature DB >> 11212296

Integrin antagonists.

G P Curley1, H Blum, M J Humphries.   

Abstract

Integrins are a family of cell surface glycoproteins that mediate numerous cell-cell and cell-matrix interactions and are involved in biological processes such as tissue morphogenesis, leukocyte recirculation and migration, wound healing, blood clotting and immune response. Aberrant cell adhesion has been implicated in the pathogenesis of several diseases, including a number of inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease and asthma, as well as cancer and coronary heart disease. As such integrins are seen as excellent targets for the development of therapeutic agents. This report begins with an examination of the structure of integrin molecules and their ligands and then goes on to review the current state of development of antiintegrin antagonists.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11212296     DOI: 10.1007/s000180050443

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  19 in total

1.  Targeted therapies for killing tumor cells.

Authors:  A F Gazdar; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Discovery and Characterization of a Potent and Specific Peptide Ligand Targeting Endothelial Progenitor Cells and Endothelial Cells for Tissue Regeneration.

Authors:  Dake Hao; Wenwu Xiao; Ruiwu Liu; Priyadarsini Kumar; Yuanpei Li; Ping Zhou; Fuzheng Guo; Diana L Farmer; Kit S Lam; Fengshan Wang; Aijun Wang
Journal:  ACS Chem Biol       Date:  2017-03-02       Impact factor: 5.100

Review 3.  The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer.

Authors:  Hannah E Majeski; Jing Yang
Journal:  Mol Pharmacol       Date:  2016-10-14       Impact factor: 4.436

4.  Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy.

Authors:  Lei Jiang; Zheng Miao; Richard H Kimura; Hongguang Liu; Jennifer R Cochran; Cathy S Culter; Ande Bao; Peiyong Li; Zhen Cheng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-10       Impact factor: 9.236

Review 5.  Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins.

Authors:  Johannes A Eble; Flávia Figueiredo de Rezende
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

6.  Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.

Authors:  Richard H Kimura; Zhen Cheng; Sanjiv Sam Gambhir; Jennifer R Cochran
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

7.  Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.

Authors:  Richard H Kimura; Aron M Levin; Frank V Cochran; Jennifer R Cochran
Journal:  Proteins       Date:  2009-11-01

8.  Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities.

Authors:  Adam P Silverman; Aron M Levin; Jennifer L Lahti; Jennifer R Cochran
Journal:  J Mol Biol       Date:  2008-11-12       Impact factor: 5.469

9.  Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome.

Authors:  Ayele H Negussie; Jenna L Miller; Goutham Reddy; Steven K Drake; Bradford J Wood; Matthew R Dreher
Journal:  J Control Release       Date:  2010-01-11       Impact factor: 9.776

10.  Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3.

Authors:  Maria Risager Jensen; Goran Bajic; Xianwei Zhang; Anne Kjær Laustsen; Heidi Koldsø; Katrine Kirkeby Skeby; Birgit Schiøtt; Gregers R Andersen; Thomas Vorup-Jensen
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.